title: Adverse events with everolimus in BOLERO-2.
authors.affiliation: Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, KULeuven (University of Leuven), Leuven, Belgium. Electronic address: patrick.neven@uzleuven.be.
authors.forename: P
authors.initials: P
authors.lastname: Neven
authors.affiliation: Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, KULeuven (University of Leuven), Leuven, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Poppe
authors.affiliation: Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, KULeuven (University of Leuven), Leuven, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Berteloot
authors.affiliation: Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, KULeuven (University of Leuven), Leuven, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Wolter
authors.affiliation: Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, KULeuven (University of Leuven), Leuven, Belgium.
authors.forename: H
authors.initials: H
authors.lastname: Wildiers
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000473:pathology*; D005260:Female; D006801:Humans; D020123:Sirolimus / Q000031:analogs & derivatives*
chemical_list: D020123:Sirolimus